Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220013685 220008112 1.88 87.1 Curative (C) 2016-04-24 2016-08-14 AML18 PILOT TRIAL Y N 220030863 PILOT TRIAL
220013686 220008113 1.75 0 Disease modification (D) 2013-05-16 2015-04-07 Rituximab N N 220030865 RITUXIMAB
220013687 220008114 1.56 0 Palliative (P) 2017-08-17 2017-08-17 Dasatinib N N 220030868 DASATINIB
220013688 220014429 null null Curative (C) 2014-07-09 2015-06-03 Dasatinib null N 220030871 DASATINIB
220013689 220008115 1.73 81.3 Curative (C) 2017-10-15 2017-12-29 AML 18 TRIAL Y N 220030873 AML18 TRIAL
220013690 220008115 1.66 113.8 Curative (C) 2017-11-04 2017-11-17 AML 18 TRIAL N null 220030873 AML18 TRIAL
220013691 220008117 1.59 60.7 Neo-adjuvant (N) 2013-07-16 2013-07-16 Dasatinib 02 N 220030880 DASATINIB
220013692 220019809 null 70.6 Curative (C) 2017-01-13 2017-01-27 Alemtuz+Fludara+Melphalan RIC MUD 02 N 220030885 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220013693 220008118 null null Curative (C) 2016-01-18 2016-01-18 Rituximab N null 220030886 RITUXIMAB
220013694 220008118 1.65 0 Palliative (P) null 2014-09-13 AML 18 TRIAL N N 220030886 AML18 TRIAL
220013695 220017877 1.88 79.6 Curative (C) 2013-07-31 2013-09-03 Rituximab N null 220030888 RITUXIMAB
220013697 220008120 1.69 60.8 Curative (C) 2013-08-16 2013-11-06 AML 18 Pilot Trial Y N 220030896 PILOT TRIAL
220013698 220008121 1.71 null Not known (9) 2014-10-11 2014-10-11 Rituximab 02 N 220030898 RITUXIMAB
220013699 220014435 1.58 57.8 Curative (C) null 2015-12-24 Alemtuz+Fludara+Melphalan RIC MUD 2 N 220030901 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220013701 220008125 0 null Curative (C) 2017-05-19 2017-05-30 AML 18 TRIAL 01 N 220030906 AML18 TRIAL
220013702 220008127 null null Disease modification (D) null 2017-01-23 Rituximab 02 N 220030913 RITUXIMAB
220013703 220014438 null null Palliative (P) 2014-09-24 2014-09-29 Dasatinib N N 220030915 DASATINIB
220013705 220008130 1.79 null Disease modification (D) 2013-12-08 2013-12-10 Dasatinib 99 null 220030919 DASATINIB
220013706 220008132 1.71 80.75 Curative (C) 2014-10-13 2014-10-23 AML 18 TRIAL Y N 220030921 AML18 TRIAL
220013707 220008133 1.75 58.9 Curative (C) 2013-12-18 2013-12-21 AML 18 TRIAL N N 220030929 AML18 TRIAL
220013708 220008134 1.8 null Palliative (P) 2013-09-02 2014-09-18 Dasatinib 2 N 220030929 DASATINIB
220013709 220008135 1.84 87.5 Curative (C) 2017-07-19 2017-07-19 Alemtuz+Fludara+Melphalan RIC MUD N N 220030936 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220013710 220008136 null 62.5 Curative (C) 2017-04-23 2017-08-02 AML18 PILOT TRIAL Y N 220030936 PILOT TRIAL
220013711 220014442 null 54.8 Curative (C) 2015-10-18 2016-04-01 Alemtuz+Fludara+Melphalan RIC MUD 2 N 220030939 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220013712 220019810 1.61 44.4 Curative (C) 2014-02-27 2014-03-17 AML 18 TRIAL Y N 220030945 AML18 TRIAL
220013713 220014443 1.68 0 Curative (C) null 2015-02-13 Dasatinib N N 220030950 DASATINIB
220013714 220008140 1.66 66 Curative (C) 2016-05-18 2016-09-07 Dasatinib 2 N 220030950 DASATINIB
220013715 220008141 null 41 Palliative (P) 2018-08-19 2018-08-19 Dasatinib N null 220030955 DASATINIB
220013718 220008151 1.6 57.8 Curative (C) 2014-07-26 2014-08-17 ALEMTUZUMAB + FLUDARABINE + MELPHALAN 2 N 220030960 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220013719 220014450 1.48 63.5 Neo-adjuvant (N) 2013-04-12 2013-10-11 Dasatinib 02 N 220030962 DASATINIB
220013720 220008155 null 82 Curative (C) 2014-05-22 2014-05-22 ALEMTUZUMAB + FLUDARABINE + MELPHALAN 2 N 220030962 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220013721 220017886 null 93.15 Curative (C) 2013-11-13 2013-11-13 Alemtuz+Fludara+Melphalan RIC MUD null N 220030966 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220013722 220008156 1.6 65.2 Palliative (P) 2016-08-14 2016-08-15 Dasatinib N N 220030970 DASATINIB
220013723 220008157 1.7 61.8 Curative (C) 2013-10-10 2014-01-19 AML 18 TRIAL Y N 220030971 AML18 TRIAL
220013724 220014453 null 59 Curative (C) 2017-11-03 2017-11-03 Alemtuz+Fludara+Melphalan RIC MUD N N 220030973 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220013725 220014453 1.7 null Curative (C) 2016-03-30 2016-04-05 Alemtuz+Fludara+Melphalan RIC MUD 2 N 220030973 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220013726 220008159 1.66 null Curative (C) 2015-02-17 2015-05-11 Dasatinib 99 N 220030977 DASATINIB
220013727 220008160 1.61 72.8 Palliative (P) 2018-04-24 2018-05-11 Rituximab N N 220030983 RITUXIMAB
220013728 220008162 1.65 58.5 Curative (C) 2014-06-03 2014-06-03 AML 18 TRIAL 1 N 220030983 AML18 TRIAL
220013729 220019816 1.8 null Disease modification (D) 2016-01-29 2016-02-02 Rituximab 2 N 220030988 RITUXIMAB
220013730 220008163 1.66 100 Curative (C) 2018-11-05 2018-11-08 AML 18 TRIAL N null 220030991 AML18 TRIAL
220013735 220008173 1.74 103.8 Curative (C) 2018-01-17 2018-01-20 ALEMTUZUMAB + FLUDARABINE + MELPHALAN N N 220031003 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220013736 220014458 1.88 68 Disease modification (D) 2015-09-09 2015-09-09 ALEMTUZUMAB + FLUDARABINE + MELPHALAN 2 N 220031003 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220013737 220008174 null 73 null 2015-11-06 2015-12-27 AML 18 TRIAL 01 null 220031014 AML18 TRIAL
220013738 220008174 1.49 70.1 Curative (C) 2017-02-08 2017-02-09 AML 18 TRIAL Y null 220031014 AML18 TRIAL
220013739 220008174 1.84 114 Curative (C) 2017-09-19 2017-10-20 Alemtuz+Fludara+Melphalan RIC MUD N N 220031014 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220013740 220017893 1.62 null Palliative (P) 2019-01-12 2019-01-12 Dasatinib 2 null 220031027 DASATINIB
220013741 220021898 1.58 78 Curative (C) 2016-03-21 2016-03-26 Alemtuz+Fludara+Melphalan RIC MUD N N 220031038 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220013742 220008176 1.96 95 Curative (C) 2017-03-17 2017-03-25 Alemtuz+Fludara+Melphalan RIC MUD N null 220031040 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220013743 220014461 1.67 54 Disease modification (D) 2014-04-28 2014-04-29 Rituximab null N 220031045 RITUXIMAB